XML 46 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2018
Stockholders' Equity Note [Abstract]  
Schedule of cash dividends declared on Series B preferred stock
The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2016 through December 31, 2018:
Year
 
Declaration Date 
 
Record Date
 
Payment Date
 
Dividend Per Share
2018
 
November 26, 2018
 
December 7, 2018
 
December 28, 2018
 
$0.46875
 
 
August 20, 2018
 
September 7, 2018
 
September 28, 2018
 
0.46875
 
 
May 17, 2018
 
June 4, 2018
 
June 29, 2018
 
0.46875
 
 
February 20, 2018
 
March 2, 2018
 
March 30, 2018
 
0.46875
 
 
 
 
 
 
 
 
 
2017
 
November 17, 2017
 
December 1, 2017
 
December 29, 2017
 
$0.46875
 
 
August 10, 2017
 
September 1, 2017
 
September 29, 2017
 
0.46875
 
 
May 16, 2017
 
June 2, 2017
 
June 30, 2017
 
0.46875
 
 
February 17, 2017
 
March 6, 2017
 
March 31, 2017
 
0.46875
 
 
 
 
 
 
 
 
 
2016
 
November 22, 2016
 
December 6, 2016
 
December 30, 2016
 
$0.46875
 
 
August 12, 2016
 
September 2, 2016
 
September 30, 2016
 
0.46875
 
 
May 18, 2016
 
June 3, 2016
 
June 30, 2016
 
0.46875
 
 
February 12, 2016
 
February 29, 2016
 
March 31, 2016
 
0.46875
Schedule of cash dividends declared on common stock
The following table presents cash dividends declared by the Company on its common stock from January 1, 2016 through December 31, 2018:
 
Year
 
Declaration Date 
 
Record Date
 
Payment Date
 
Dividend Per Share
 
2018
 
December 12, 2018
 
December 28, 2018
 
January 31, 2019
 
$0.20
(1)
 
 
September 13, 2018
 
October 1, 2018
 
October 31, 2018
 
0.20
 
 
 
June 7, 2018
 
June 29, 2018
 
July 31, 2018
 
0.20
 
 
 
March 7, 2018
 
March 29, 2018
 
April 30, 2018
 
0.20
 
 
 
 
 
 
 
 
 
 
 
2017
 
December 13, 2017
 
December 28, 2017
 
January 31, 2018
 
$0.20
 
 
 
September 14, 2017
 
September 28, 2017
 
October 31, 2017
 
0.20
 
 
 
June 12, 2017
 
June 29, 2017
 
July 28, 2017
 
0.20
 
 
 
March 8, 2017
 
March 29, 2017
 
April 28, 2017
 
0.20
 
 
 
 
 
 
 
 
 
 
 
2016
 
December 14, 2016
 
December 28, 2016
 
January 31, 2017
 
$0.20
 
 
 
September 15, 2016
 
September 28, 2016
 
October 31, 2016
 
0.20
 
 
 
June 14, 2016
 
June 28, 2016
 
July 29, 2016
 
0.20
 
 
 
March 11, 2016
 
March 28, 2016
 
April 29, 2016
 
0.20



(1)  At December 31, 2018, the Company had accrued dividends and dividend equivalents payable of $90.2 million related to the common stock dividend declared on December 12, 2018.
Public Offering of Common Stock
The table below presents information with respect to shares of the Company’s common stock issued through public offerings during the years ended December 31, 2018 and 2017.
Share Issue Date
 
Shares Issued
 
Gross Proceeds Per Share
 
Gross Proceeds
 
(In Thousands, Except Per Share Amounts)
 
 
 
 
 
 
 
August 7, 2018
 
50,875

(1
)
$
7.78

 
$
395,807

(1)
May 10, 2017
 
23,000

 
$
7.85

 
$
180,550

(2)

(1) Includes approximately 875,000 shares issued on September 5, 2018 pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company incurred approximately $6.4 million of underwriting discounts and related expenses in connection with this equity offering.
(2) The Company incurred approximately $2.3 million of underwriting discounts and related expenses in connection with this equity offering.
Schedule of changes in balances in each component of the entity's AOCI
The following table presents changes in the balances of each component of the Company’s AOCI for the years ended December 31, 2018, 2017 and 2016:

 
 
For the Year Ended December 31,
 
 
2018
 
2017
 
2016
(In Thousands)
 
Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
Gain/(Loss)
on Swaps
 
Total 
AOCI
 
Net 
Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
Gain/(Loss)
on Swaps
 
Total 
AOCI
 
Net 
Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
Gain/(Loss)
on Swaps
 
Total 
AOCI
Balance at beginning of period
 
$
620,648

 
$
(11,424
)
 
$
609,224

 
$
620,403

 
$
(46,721
)
 
$
573,682

 
$
585,250

 
$
(69,399
)
 
$
515,851

OCI before reclassifications
 
(150,642
)
 
14,545

 
(136,097
)
 
39,984

 
35,297

 
75,281

 
72,560

 
22,678

 
95,238

Amounts reclassified from
  AOCI (1)
 
(52,839
)
 
—

 
(52,839
)
 
(39,739
)
 
—

 
(39,739
)
 
(37,407
)
 
—

 
(37,407
)
Net OCI during period (2)
 
(203,481
)
 
14,545

 
(188,936
)
 
245

 
35,297

 
35,542

 
35,153

 
22,678

 
57,831

Balance at end of period
 
$
417,167

 
$
3,121

 
$
420,288

 
$
620,648

 
$
(11,424
)
 
$
609,224

 
$
620,403

 
$
(46,721
)
 
$
573,682



(1)  See separate table below for details about these reclassifications.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
Information about the significant amounts reclassified out of the entity's AOCI
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the years ended December 31, 2018, 2017, and 2016:
 
 
For the Year Ended December 31,
 
 
 
 
2018
 
2017
 
2016
 
 
Details about AOCI Components
 
Amounts Reclassified from AOCI
 
Affected Line Item in the Statement
Where Net Income is Presented
(In Thousands)
 
 
 
 
 
 
 
 
AFS Securities:
 
 
 
 
 
 
 
 
Realized gain on sale of securities
 
$
(51,580
)
 
$
(38,707
)
 
$
(36,922
)
 
Net realized gain on sales of residential mortgage securities
OTTI recognized in earnings
 
(1,259
)
 
(1,032
)
 
(485
)
 
Other, net
Total AFS Securities
 
$
(52,839
)
 
$
(39,739
)
 
$
(37,407
)
 
 
Total reclassifications for period
 
$
(52,839
)
 
$
(39,739
)
 
$
(37,407
)